Impact of orphan drugs on Latvian budget

BACKGROUND: Number of orphan medicinal products on the market and number of rare disease patients, taking these usually expensive products, are increasing. As a result, budget impact of orphan drugs is growing. This factor, along with the cost-effectiveness of orphan drugs, is often considered in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Logviss, Konstantins, Krievins, Dainis, Purvina, Santa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864910/
https://www.ncbi.nlm.nih.gov/pubmed/27169704
http://dx.doi.org/10.1186/s13023-016-0434-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864910/
https://www.ncbi.nlm.nih.gov/pubmed/27169704
http://dx.doi.org/10.1186/s13023-016-0434-y

Ejemplares similares